4D Pharma requests immediate suspension of its shares
Biotherapeutics developer 4D Pharma requested an immediate suspension of trading in its shares on Friday.
The AIM-traded firm said it made the request pending a further announcement.
No further explanation was offered by the company.
“A further announcement will be made as soon as practicable,” the board said in its short statement.
Reporting by Josh White at Sharecast.com.